- Release Date: 29/06/11 10:12
- Summary: Results of Impairment Review
- Price Sensitive: Yes
- Download Document 1MB
- Forums
- ASX - By Stock
- TPA
- Ann: Results of Impairment Review
Featured News
RCE
Phase II clinical trial recruitment for R327G topical gel passes halfway, showing promising results against bacterial skin infections
LU7
The Breakdown: Lithium Universe talks refinery design and lithium processing in strong preliminary feasibility study for Bécancour
Add TPA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
EL8
ELEVATE URANIUM LTD
Murray Hill, MD & CEO
Murray Hill
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online